Managing the neuropsychiatric symptoms of Parkinson's disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 9633685.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neuropsychiatric symptoms frequently complicate the treatment of Parkinson's disease (PD). Approximately 27% of PD patients are demented, and approximately 19% are cognitively impaired without being demented. These 46% of patients are prone to development of delirium when they take antiparkinsonian drugs. Approximately 40% of PD patients are depressed. The depression may be endogenous or exogenous, apathetic or agitated. Approximately 40% of PD patients are anxious or have panic attacks. The attacks may or may not be associated with depression. This article reviews the diagnosis of these symptoms and discusses their management.
Medical subject headings
- Antiparkinson Agents
- Dementia
- Neuropsychological Tests
- Parkinson Disease
- Psychotropic Drugs